David Randolph, MD
Radiation Oncology · Norfolk, VANPI 1447216866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 33.8% of the total. Reporting peaked in 2024 at $197 and has fallen 51.5% since, to $95 in 2025.
Across 22 payments — averaging $26.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$196
- Merck$137
- Elekta, Inc.$70
- Varian Medical Systems, Inc.$61
- Seagen Inc.$41
- Boston Scientific$26
- plus $47 from 2 others
What the payments were for
- Food & beverage$580100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $196 |
| Merck | 7 | $137 |
| Elekta, Inc. | 1 | $70 |
| Varian Medical Systems, Inc. | 1 | $61 |
| Seagen Inc. | 2 | $41 |
| Boston Scientific | 1 | $26 |
| Palette Life Sciences, Inc. | 1 | $25 |
| Medtronic | 1 | $22 |
How this compares
$580 in reported general payments places this provider in the 60th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 41 | $839 |
| Oxycodone Hcl | 32 | $323 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $228 |
| Levofloxacin | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Norfolk
- Lara Bonner MillarNorfolk$6K
- Jacob HallNorfolk$4K
- Edwin CrandleyNorfolk$1K
- Scott WilliamsNorfolk$871
- Heather JonesNorfolk$445
- Mark ShavesNorfolk$419
- Daniel KimFairfax$406K
- Samir KananiFairfax$90K
- David PenberthyCharlottesville$67K
- Gopal BajajFairfax$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.